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 ABSTRACT 
 Bovine mastitis, an inflammatory disease of the mam-
mary gland, is one of the most costly diseases affecting 
the dairy industry. The treatment and prevention of 
this disease is linked heavily to the use of antibiotics in 
agriculture and early detection of the primary pathogen 
is essential to control the disease. Milk samples (n = 
67) from cows suffering from mastitis were analyzed 
for the presence of pathogens using PCR electrospray-
ionization mass spectrometry (PCR/ESI-MS) and were 
compared with standard culture diagnostic methods. 
Concurrent identification of the primary mastitis patho-
gens was obtained for 64% of the tested milk samples, 
whereas divergent results were obtained for 27% of 
the samples. The PCR/ESI-MS failed to identify some 
of the primary pathogens in 18% of the samples, but 
identified other pathogens as well as microorganisms 
in samples that were negative by culture. The PCR/
ESI-MS identified bacteria to the species level as well 
as yeasts and molds in samples that contained a mixed 
bacterial culture (9%). The sensitivity of the PCR/ESI-
MS for the most common pathogens ranged from 57.1 
to 100% and the specificity ranged from 69.8 to 100% 
using culture as gold standard. The PCR/ESI-MS 
also revealed the presence of the methicillin-resistant 
gene mecA in 16.2% of the milk samples, which corre-
lated with the simultaneous detection of staphylococci 
including Staphylococcus aureus. We demonstrated 
that PCR/ESI-MS, a more rapid diagnostic platform 
compared with bacterial culture, has the significant 
potential to serve as an important screening method 
in the diagnosis of bovine clinical mastitis and has the 
capacity to be used in infection control programs for 
both subclinical and clinical disease. 
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 INTRODUCTION 
 Bovine mastitis, an inflammatory and infectious 
disorder of the udder tissue in cows, often occurs in 
response to bacterial invasion, and less frequently to 
invasion by molds, yeasts, Prototheca, and viruses 
(Wellenberg et al., 2002; Rakesh et al., 2006; Möller et 
al., 2007; Zadoks et al., 2011). The economic effect of 
bovine mastitis is significant, and in some cases nearly 
10% of total milk production is unusable (Seegers et 
al., 2003; Halasa et al., 2007; Hogeveen et al., 2011). 
The diagnosis of clinical bovine mastitis is based on 
the abnormal appearance of milk, visible and or palpa-
tory changes in the udder, and elevated SCC (Ruegg, 
2003). Subclinical infections, however, are economically 
more problematic and clinical signs are not obvious, 
as the milk appears normal despite an increased SCC. 
Microbiological examination of the milk is necessary 
to determine the cause of the infection and allow vet-
erinarians to use appropriate therapeutic measures. To 
date, cultures of the pathogens and microscopy remain 
the most common approaches to identify the pathogens 
in milk. However, the samples may contain a large vari-
ety of microorganisms, making the identification of the 
primary pathogens very difficult. Additionally, mastitis 
may be caused by slow-growing bacteria, such as My-
coplasma spp., which require special growth medium, 
thus delaying diagnosis. To overcome these problems, 
PCR-based methods have been developed; they are 
frequently restricted to a limited number of pathogens, 
however (Viguier et al., 2009; Ajitkumar et al., 2012). 
 Multiple PCR followed by electrospray-ionization 
mass spectrometry (PCR/ESI-MS) has been devel-
oped to rapidly detect nearly all known pathogens, 
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including those causing bovine mastitis, as well as some 
important antibiotic-resistant genes. This technology 
consists of DNA amplification by PCR of specific re-
gions of ribosomal and conserved house-keeping genes, 
as well as some antibiotic-resistant genes, which are 
electrosprayed into a time-of-flight MS for molecular 
weight measurement. The mass of each amplicon is 
translated into base composition for organism and 
antibiotic-resistant gene identification (see Ecker et al., 
2008, and Wolk et al., 2012, for reviews of the method-
ology, flow scheme, and laboratory application). This 
technology has also found applications in human clini-
cal diagnostics (Arciola et al., 2011; Wolk et al., 2012). 
The objective of this pilot study was to assess whether 
PCR/ESI-MS can be a useful technology for the rapid 
identification of bovine mastitis-causing pathogens 
compared with standard milk cultures. Earlier and 
more precise detection of the pathogens would help to 
identify risk factors for bovine mastitis and aid in the 
therapeutic strategy, as well as in the development of 
appropriate screening and control programs.
MATERIALS AND METHODS
Milk Sampling
Milk samples (10 mL) were prospectively collected 
aseptically from cows affected by clinical (changes in 
secretion or changes in the consistency of the mammary 
gland) and subclinical mastitis (SCC > 150,000 cells/
mL) and from healthy cows (SCC < 150,000 cells/mL) 
in Switzerland. Cows were selected according to their 
last individual SCC test day as measured using a Fosso-
matic 500 cell counter (Foss, Hillerød, Denmark), and a 
California Mastitis Test was performed after forestrip-
ping as described previously (Barnum and Newbould, 
1961). A threshold of ≥800,000 to 5,000,000 cells/mL, 
providing a sensitivity of 72% and a specificity of 64% 
for detecting IMI, was used (Ruegg 2003). Eight millili-
ters of milk were used directly for bacteriological analy-
sis and the remaining 2 mL were shipped overseas at 
room temperature without preservatives for subsequent 
DNA extraction and PCR/ESI-MS analyses.
Bacteria Isolation and Identification
Milk samples were centrifuged at 590 × g for 10 min 
at room temperature. Cultivating for the common milk 
pathogens, one loop-full (10 μL) of the resulting pellet 
and supernatant was plated directly onto tryptone soy 
agar plates containing 5% sheep blood (TSA-SB; BD, 
Franklin Lakes, NJ) and onto selective bromothymol-
blue lactose (Brolac; bioMérieux SA, Marcy-l’Étoile, 
France) agar plates. The TSA-SB plates were incubated 
with 5% CO2 for 24 h for the detection of microaero-
philic bacteria, such as Histophilus somni, and for an-
other 24 h at 37°C under aerobic conditions to support 
the growth of strict aerobic bacteria. Brolac agar plates 
were incubated under aerobic conditions at 37°C for 24 
to 48 h for the detection of lactose-positive or negative 
bacteria and the specific growth of yeast. Additionally, 
samples suspected of containing Aspergillus spp. were 
cultivated on Sabouraud Agar (Oxoid, Basingstoke, 
UK); those suspected of containing Mycoplasma bovis 
were cultivated on specific Mycoplasma agar (Oxoid) at 
37°C for 2 to 5 d.
Staphylococcus aureus was identified on TSA-SB agar 
plates based on the production of an α- and β-(double) 
hemolysis. α-Hemolytic Staph. aureus were identified 
using chromogenic agars SA select (Bio-Rad, Hercules, 
CA) and Staph. aureus ID agar (bioMérieux). Other 
species of staphylococci (non-aureus Staphylococcus 
spp., including CNS) were not further identified. Strep-
tococci, enterocococci, and lactococci were identified 
using a biochemical scheme described previously (Gué-
lat-Brechbuehl et al., 2010). Enterobacteriaceae (e.g., 
Escherichia coli) were identified by microscopy, lactose 
fermentation, and indole production assays. Coryne-
bacterium bovis, Arcanobacterium pyogenes, yeasts, and 
Prothoteca were identified by microscopy or phenotypic 
reactions using Vitek Compact 2 (bioMérieux).
Anaerobic bacteria were identified by direct micros-
copy of the milk pellet and strict anaerobic growth on 
TSA-SB. Aspergillus spp. were identified by microscopic 
morphology and by specific coloration appearance on 
Sabouraud agar. Mycoplasma bovis was identified by 
PCR (Subramaniam et al., 1998). Plates grown with a 
layer or with more than 3 microorganisms displaying 
different morphology were considered as containing a 
mixture of bacteria, which were not further identified 
by culture. A method of semiquantification [few (>30 
colonies), moderate (30–100), or many (>100)] was 
used to report the relative numbers of bacteria present 
in the milk samples (Washington, 1996).
PCR/ESI-MS
The DNA for PCR/ESI-MS was extracted from 1 mL 
of each milk samples using a method that combines bead-
beating cell lysis with a magnetic-bead base extraction 
(Abbott, Des Plaines, IL). Briefly, the milk was mixed 
with proteinase K, and 20% SDS solution was mixed 
with the extraction control in a tube containing 1.5 g of 
0.2-mm yttrium-stabilized zirconium oxide beads. The 
mixture was then homogenized in a tissue homogenizer 
(Precellys 24, Bioamerica Inc., Miami, FL) at 6,200 
rpm for 90 s three times, with 5-s intervals between 
events. Each homogenized lysate was incubated at 56°C 
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for 15 min and then centrifuged for 3 min at 16,000 × 
g in a bench-top microcentrifuge. Next, DNA from the 
lysate was isolated using a magnetic particle processor 
(Kingfisher Flex, Thermo Scientific, Waltham, MA). 
The lysate was transferred to a 24 deep-well plate along 
with lysis buffer and magnetic particles. Each lysate 
mixture was incubated for 16.5 min in the lysis buffer 
at 56°C. Specimens were then washed once in wash buf-
fer 1, and 3 times in wash buffer 2 (1-min incubation 
for each wash step). The magnetic beads were then 
dried for 3 min at 65°C, and nucleic acids were eluted 
into 250 μL of DNA/RNA-free water by incubating the 
magnetic particles at 65°C for 3 min. The PCR/ESI-
MS analyses were performed on the PLEX-ID using the 
PLEX-ID BAC Detection assay (Cat. No. 05N13–62, 
Abbott) for the detection and identification of more 
than 3,400 species of bacteria, 40 species of Candida, 
and 4 antibiotic-resistant markers (mecA, vanA, vanB, 
and blaKPC) direct from the sample. All groups of bac-
teria, including intracellular organisms such as Myco-
plasma, Chlamydia, and Rickettsia and hard to culture 
or nonculturable organisms, could be detected by this 
assay. Analysis was performed using the software ver-
sion 2.6.052 (Ibis Biosciences; Ecker et al., 2008). The 
PLEX-ID BAC Detection assay has a DNA calibrant in 
each reaction, which allows for semiquantitative analy-
sis (Hofstadler et al., 2005). By comparing the relative 
intensity of the target DNA to that of the calibrant, the 
relative concentration of target DNA initially present is 
determined (Ecker et al., 2008).
The PLEX-ID BAC assay uses signal thresholds 
(cutoffs) designed to limit reporting of irreproducible 
detections. Cutoffs are applied to 2 measurements. The 
first, termed the level, is an indication of the amount of 
the amplicon present in the sample reported as genome 
equivalents (GE) per well. This is calculated with ref-
erence to the internal calibrant and has been described 
previously (Hofstadler et al., 2005). The linear range 
for reporting these levels is between 0.1× and 10× the 
levels of internal controls in the assay, which, in the 
case of the fungal assay, represents a working range of 
~2 GE/well to 200 GE/well. The second is the quality 
score (Q-score), which represents a relative measure of 
the strength of the data supporting identification. The 
Q-Score is a rating between 0 (low) and 1 (high), based 
on several parameters. Parameters include an indicator 
of how well the hypothesized organisms, as a group, 
represent the observed data; an indicator of how signifi-
cant the contribution of a single organism is to the solu-
tion; the fraction of missed detections, which represents 
the percentage of primers for a detected organism that 
should have produced known base count compositions, 
but did not; and, finally, the percentage of primers for 
a detected organism for which no known data exists 
within the PLEX-ID system. The Q-score cutoffs are 
designed to prevent reporting (positive identification) 
of specific organisms when the information obtained 
is not sufficient to confidently resolve the organism’s 
identity. For the PLEX-ID BAC assay, a Q-score ≥ 
0.85 is considered a reportable result. The specificity 
and sensitivity of the PCR/ESI-MS method was deter-
mined using culture as gold standard.
RESULTS
A total of 67 milk samples originating from 21 cows 
with clinical mastitis, 34 cows with subclinical mastitis, 
and 12 healthy cows were analyzed using both standard 
bacteriology and PCR/ESI-MS analysis. Overall, a 
64.1% agreement was observed between the 2 methods, 
with results concurrent with both methods for 43 milk 
samples (Table 1, samples 1–43). Among them, PCR/
ESI-MS and cultures generated the exactly same results 
for 18 milk samples (Table 1, samples 1–18). In the 
other 24 milk samples with concurrent results, PCR/
ESI-MS identified additional microorganisms in 18 
milk samples compared with culture (Table 1, samples 
19–36), whereas culture revealed additional microor-
ganisms in only 3 milk samples compared with PCR/
ESI-MS (Table 1, samples 37–39). Besides a concur-
rent identification of 1 type of microorganism in 4 milk 
samples, PCR/ESI-MS and cultures both identified 
additional but different organisms (Table 1, samples 
40–43). Both methods revealed the presence of CNS 
in 12 milk samples: Streptococcus uberis (7 samples), 
Streptococcus dysgalactiae (1 sample), Staph. aureus 
(4 samples), C. bovis (3 samples), Mycoplasma spp. (2 
samples), A. pyogenes (3 samples), Enterococcus spp. 
(4 samples), Enterobacteriaceae (2 samples), as well as 
the absence of detectable microorganisms in 4 samples 
(Table 1, samples 15–18). Specific identification of the 
pathogens could not be made by culture or by PCR/
ESI-MS for 2 milk samples, but both methods identi-
fied a mixture of different bacteria in one sample and 
a mixture of anaerobic bacteria in the other (Table 1, 
samples 10 and 14). Otherwise, PCR/ESI-MS allowed 
identification of bacteria to the species level, as well as 
yeast and fungi.
Indeed, in 6 additional samples containing a mixture 
of bacteria (8.8%) consisting of more than 3 different 
microorganisms, which are routinely not further identi-
fied individually, PCR/ESI-MS allowed identification 
of CNS (Staphylococcus sciuri, Staphylococcus vitulinus, 
Staphylococcus xylosus, Staphylococcus equorum) in 
all samples and also yeasts (Candida albicans), molds 
(Penicillium marneffei), Pseudomonas spp., Acineto-
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Continued
Table 1. List of samples that generated concurrent results when analyzed with standard culture identification and PCR electrospray-ionization mass spectrometry (PCR/ESI-MS) 
Sample  
no. Milk no. Mastitis
Standard  
identification
Number  
of colonies
PCR/ESI-MS
Agreement
Broader  
identification
Genomes/ 
well1 Q-score2 Identification
1 M0439 Clinical Staphylococcus aureus <30 166 1 Staph. aureus3 Yes None
2 M0671 Subclinical Staph. aureus >100 220 1 Staph. aureus3 Yes None
3 M0478 Clinical Streptococcus uberis >100 852 0.87 Strep. uberis3 Yes None
4 M0479 Clinical Strep. uberis >100 64 0.97 Strep. uberis3 Yes None
5 JM0501 Clinical Strep. uberis 30–100 149 1 Strep. uberis3 Yes None
6 M2716 Subclinical Strep. uberis >100 226 1 Strep. uberis3 Yes None
7 M0625 Control Corynebacterium bovis 30–100 297 1 C. bovis3 Yes None
8 M2745 Clinical Mycoplasma spp.    Mycoplasma spp.3 Yes None
9 M2744 Clinical Arcanobacterium pyogenes >100 7 0.92 Arcanobacterium spp.3 Yes None
   Mycoplasma spp.  1,344 0.92 Mycoplasma spp.3   
10 M2727 Subclinical A. pyogenes >100 19 0.96 Arcanobacterium spp.3 Yes None
   Mix of anaerobes >100   Firmicutes (anaerobes)   
11 M2746 Subclinical Enterococcus spp. 30–100 74 0.99 Enterococcus faecalis3 Yes None
12 M2741 Subclinical CNS <30 60 0.99 Staphylococcus xylosus3 Yes PCR/ESI-MS
13 M2786 Subclinical CNS 30–100 153 1 Staph. xylosus3 Yes PCR/ESI-MS
     7 1 mecA   
14 M0472 Clinical Mix of bacteria <30 NA4 NA Unidentified complex mixture Yes None
15 M0667 Subclinical No growth  NA NA Negative Yes None
16 M0680 Subclinical No growth  NA NA Negative Yes None
17 M0682 Control No growth  NA NA Negative Yes None
18 M0689 Subclinical No growth  NA NA Negative Yes None
19 M0421 Subclinical CNS <30 79 1 Staphylococcus saprophyticus3 Yes PCR/ESI-MS
     28 0.87 Gemella hemolysans5   
     99 1 Candida parapsilosis3   
     175 1 mecA   
20 M0424 Subclinical CNS >100 96 1 Staphylococcus.simulans3 Yes PCR/ESI-MS
     1,038 0.91 Staphylococcus sciuri/Staphylococcus vitulinus3   
     41 0.95 C. bovis   
21 M0481 Subclinical CNS <30 120 0.96 Staphylococcus warneri/Staphylococcus haemolyticus Yes PCR/ESI-MS
   C. bovis <30 135 0.98 C. bovis3   
     16 0.97 Phaeosphaeria nodorum/Phaeosphaeria sp. Sn 48–15   
22 M0624 Control CNS <30 290 1 Staph. xylosus Yes PCR/ESI-MS
     52 0.89 Pseudomonas syringae5   
23 M2778 Subclinical CNS <30 338 0.99 Staph. xylosus3 Yes PCR/ESI-MS
     186 1 mecA   
       Streptococcus spp.3   
       Unknown fungus5   
24 M0626 Control CNS <30 135 1 Staph. xylosus Yes PCR/ESI-MS
   Mix of bacteria <30 34 0.88 Pseudomonas. fluorescens   
     13 0.86 Pseudomonas. entomophila/Pseudomonas. putida   
25 M0426 Clinical Staph. sciuri <30 265 1 Staph. sciuri/Staph. vitulinus3 Yes PCR/ESI-MS
   Mix of bacteria <30 164 0.86 Enterococcus faecium3   
     51 0.95 Candida famata3   
     193 1 mecA   
26 M2750 Subclinical Staph. aureus 30–100 88 0.99 Staph. aureus3 Yes PCR/ESI-MS
       Additional firmicutes   
27 M0463 Clinical Strep. uberis <30 287 0.97 Strep. uberis3 Yes PCR/ESI-MS
     23 0.86 Staphylococcus spp.3   
28 M2810 Subclinical Strep. uberis <30 26 0.92 Strep. uberis3 Yes PCR/ESI-MS
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Table 1 (Continued). List of samples that generated concurrent results when analyzed with standard culture identification and PCR electrospray-ionization mass spectrometry 
(PCR/ESI-MS) 
Sample  
no. Milk no. Mastitis
Standard  
identification
Number  
of colonies
PCR/ESI-MS
Agreement
Broader  
identification
Genomes/ 
well1 Q-score2 Identification
     38 0.89 Pseudomonas spp.5   
       Enterobacteriaceae5   
       Unknown fungus5   
29 M2687 Subclinical Strep. uberis 30–100 120 0.93 Strep. uberis3 Yes PCR/ESI-MS
     55 0.99 Staph. xylosus3   
30 M2783 Subclinical Streptococcus dysgalactiae >100 1,672 0.90 Strep. dysgalactiae3 Yes PCR/ESI-MS
     53 0.97 Staph. xylosus3   
     4 0.90 Staph. aureus3   
31 M0464 Subclinical Yeasts >100 124 0.99 Candida tropicalis3 Yes PCR/ESI-MS
     208 1 Staph. xylosus3   
32 M0480 Clinical A. pyogenes >100 80 0.91 A. pyogenes3 Yes PCR/ESI-MS
     65 1 Staph. simulans3   
33 M2736 Subclinical C. bovis <30 16 0.97 C. bovis3 Yes PCR/ESI-MS
     17 0.94 Leuconostoc pseudomesenteroides5   
34 M2740 Clinical Enterococcus sp. <30 26 0.97 Enteroc. faecalis3 Yes PCR/ESI-MS
     10 0.94 Lactococcus lactis5   
35 M2777 Control Enterococcus sp. >100 108 0.99 Lc. lactis5 Yes PCR/ESI-MS
   CNS >100   Staph. xylosus3   
     147 1 mecA   
       Unknown fungus5   
36 M2781 Clinical Escherichia coli <30 7 0.97 E. coli3 Yes PCR/ESI-MS
     8 0.92 C. bovis3   
       Streptococcus spp.3   
37 M0664 Control CNS <30 1,509 0.92 Staph. sciuri/Staph. vitulinus3 Yes Culture
   C. bovis 30–100      
38 M0465 Clinical Strep. uberis <30 357 0.99 Strep. uberis3 Yes Culture
   Staph. aureus <30      
39 M0669 Subclinical Strep. uberis <30 183 0.99 Strep. uberis3 Yes Culture
   CNS <30      
40 M0423 Clinical Staph. aureus >100 212 0.99 Staph. aureus3 Yes Not definable
   Bacillus cereus 30–100 12 0.9 Enterobacter cancerogenus/Enterobacter cloacae 
complex5
  
     198 1 mecA   
41 M9217 Subclinical Enteroc. faecalis >100 131 0.99 Enteroc. faecalis3 Yes Not definable
   C. bovis <30 38 0.91 Pseudomonas spp.5   
42 M0668 Subclinical CNS <30 >1,000 0.92 Staph. sciuri/Staph. vitulinus3 Yes Not definable
   C. bovis <30 113 0.97 Staph. xylosus3   
     137 1 Penicillium marneffei5   
     178 1 mecA   
43 M2737 Control Enterobacteriaceae >100 89 0.98 Shigella sonnei/E. coli5 Yes Not definable
   Staph. aureus 30–100 19 0.87 Enterob. cancerogenus/Enterob. cloacae complex5   
     105 0.95 Le. mesenteroides5   
1Genome equivalents per well is an indication of the amount of the amplicon present in the sample. 
2Q-score (quality score) ≥0.85 is considered a reportable result (see Materials and Methods for details).
3Organisms known as mastitis pathogens.
4NA = not applicable.
5Organisms likely environmental in context with anamnesis (control, subclinical or clinical mastitis); 
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bacter spp. Chryseobacterium indologenes, and entero-
cocci (Enterococcus saccharolyticus and Enterococcus 
faecalis; Table 2, samples 44–49). However, PCR/ESI-
MS failed to identify the complete flora in such highly 
contaminated samples. For those samples, PCR/ESI-
MS identified only up to 2 different microorganisms 
(Table 2, samples 45–49), except for 1 sample where 
more than 3 microorganisms (Staph. xylosus, Enteroc. 
faecalis, Acinetobacter johnsonii, and C. albicans) were 
identified using PCR/ESI-MS (Table 2, sample 44).
Divergent results between the culture and the PCR/
ESI-MS methods were obtained for 18 milk samples 
(27.9%; Table 3). In this instance, PCR/ESI-MS failed 
to identify one of the primary pathogens in 17.9% 
of the samples, but it identified microorganisms in 
samples that were negative by culture (9%) as well as 
other pathogens (3%). In one sample, PCR/ESI-MS 
identified Pseudomonas spp. instead of C. bovis (Table 
3, sample 50). The PCR/ESI-MS only identified the 
facultative anaerobic bacteria Enterococcus spp. and 
Psychrobacter spp. in 1 milk sample that also contained 
a mix of strictly anaerobic bacteria (Table 3, sample 
51). The PCR/ESI-MS failed to identify yeasts in 1 
sample, but revealed the presence of Moraxella/Aci-
netobacter spp. and Staph. xylosus instead (Table 3, 
sample 52). The PCR/ESI-MS identified Lactococcus 
lactis in 2 milk samples, and did not detect the primary 
mastitis pathogens Staph. aureus and Strep. uberis in 
these samples (Table 3, samples 53 and 54). In 2 sam-
ples containing Strep. uberis, PCR/ESI-MS revealed 
the presence of Leuconostoc mesenteroides and fungi in 
1 sample, and Aspergillus amstelodami, Staph. aureus, 
and unknown bacteria in the other sample (Table 3, 
samples 55 and 56). In 5 samples, PCR/ESI-MS re-
mained negative, whereas bacteria such as CNS, E. coli, 
Strep. dysgalactiae, and yeasts could be cultivated on 
the agar plates (Table 3, samples 58–61). On the other 
hand, PCR/ESI-MS identified fungi as well as bacteria 
(Staph. xylosus, Staph. haemolyticus, Staph. vitulinus, 
Janthinobacterium lividum, Erwinia tasmaniensis/rha-
pontici) in 6 milk samples that remained negative on 
agar plates (Table 3, samples 62–67).
The mecA gene was detected in 11 samples (16.4%) 
and was always associated with the presence of staphy-
lococci. In one sample, mecA was associated with the 
presence of Staph. aureus (Table 1, sample 40), other-
wise it was linked to CNS (Table 1, samples 13, 19, 23, 
25, 35, and 42; Table 2, samples 44, 45, and 46; Table 
3, sample 67).
The relative quantity of microorganisms growing on 
the culture media and the genomic quantification ob-
tained by PCR/ESI-MS differed from sample to sample 
and no significant quantitative association could be 
made between both methods (Tables 1–3). Overall, Ta
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Table 3. List of results showing divergence between the culture method and PCR electrospray-ionization mass spectrometry (PCR/ESI-MS) 
Sample 
No. Milk no. Mastitis
Standard  
identification
Number  
of colonies
PCR/ESI-MS
Agreement
Broader  
identificationGE/well1 Q-score2 Identification
50 M0420 Subclinical C. bovis 30–100 101 0.94 Pseudomonas fluorescens3 No Not definable
     33 0.91 Pseudomonas stutzeri3   
     23 0.89 Enterobacter aerogenes3   
51 M2743 Subclinical Mix of anaerobes 30–100  Enterococcus species4 No Not definable
     25 0.8694 Psychrobacter spp.3   
52 M2747 Subclinical Yeasts  47 0.90 Moraxella/Acinetobacter spp.3 No Not definable
     20 0.98 Staphylococcus xylosus4   
53 M0425 Control Staph. aureus <30 153 1 Lactococcus lactis3 No Culture
   Mix of bacteria <30     
54 M0427 Subclinical Strep. uberis <30 109 1 Lc. lactis3 No Culture
   C. bovis <30     
55 M2735 Subclinical Strep. uberis 30–100 21 0.99 Leuconostoc mesenteroides3 No Not definable
      Unknown fungus3   
56 M2787 Clinical Strep. uberis >100 3 0.96 Aspergillus amstelodami3 No Not definable
      Staph. aureus4   
      Unknown bacteria   
57 M0477 Clinical CNS <30 NA5 NA Negative No Culture
58 M0422 Subclinical CNS <30 NA NA Negative No Culture
59 M2715 Subclinical Yeasts >100  Negative No Culture
60 M2721 Clinical E. coli >100  Negative No Culture
61 M2739 Clinical Strep. dysgalactiae >100  Negative No Culture
62 M0462 Clinical No growth  237 1 Staph. xylosus4 No PCR/ESI-MS
63 M0681 Subclinical No growth  49 0.9 Erwinia tasmaniensis/rhapontici3 No PCR/ESI-MS
     127 1 Staph. xylosus4   
64 M2707 Clinical No growth  811 0.88 Janthinobacterium lividum3 No PCR/ESI-MS
65 M2748 Subclinical No growth   Unknown fungus3 No PCR/ESI-MS
66 M2779 Subclinical No growth  151 0.99 Staphylococcus haemolyticus4 No PCR/ESI-MS
      Unknown fungus3  PCR/ESI-MS
67 M0627 Control No growth  153 1 Staphylococcus vitulinus4 No PCR/ESI-MS
     198 1 mecA   
1GE/well = genome equivalents per well; an indication of the amount of the amplicon present in the sample.
2Q-score (quality score) ≥0.85 is considered a reportable result (see Materials and Methods for details).
3Organisms likely environmental in context with anamnesis (control, subclinical, or clinical mastitis).
4Organisms known as mastitis pathogens.
5NA = not applicable.
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PCR/ESI-MS showed a sensitivity and specificity of 
56.8 and 59.5% compared with cultures. The specific-
ity and sensitivity increased when the detection of the 
pathogenic bacteria was considered individually; with 
57.1% sensitivity and 96.6% specificity for Staph. aure-
us, 71.4% and 96.2% for streptococci, 80.0% and 69.8% 
for CNS, 37.5% and 96.6% for C. bovis, 75% and 93.7% 
for enterococci, 33.3% and 94.4% for yeasts, 66.7% and 
95.3% for Enterobacteriaceae, and 100% sensitivity and 
specificity for M. bovis and A. pyogenes.
DISCUSSION
This is the first study that evaluates the potential of 
PCR/ESI-MS for veterinary microbiology diagnosis. In 
particular, bovine mastitis represents one of the more 
challenging diagnostic tasks due to the large heteroge-
neity of the microorganisms that may cause the disease 
and the permanent evolution of the disease through 
microbial adaptation (Bradley, 2002).
Our study demonstrates that PCR/ESI-MS appears 
to be a promising tool for the identification of the mas-
titis pathogens directly from milk using a kit developed 
for microbiological diagnosis in human medicine (Ecker 
et al., 2008). The predominant pathogen detected by 
PCR/ESI-MS in each sample was consistent with stan-
dard milk culture results in two-thirds of the examined 
samples. The PCR/ESI-MS also allowed an estimate 
of the relative abundance of microorganisms present in 
the milk samples, which may be helpful for the inter-
pretation of the results, particularly if heterogeneity ex-
ists among the types of microorganisms present in the 
milk. However, the relative number of genomic copies 
of DNA that were amplified did not always correspond 
to the relative number of microorganisms estimated 
from the cultures, likely due to the different measure-
ment techniques of the 2 semiquantitative methods. It 
should also be noted that the milk samples were sent 
overseas and remained room temperature for at least 
1 wk, which may have allowed some contaminants to 
overgrow or lead to degradation of DNA from the iso-
lates. Further validations using milk preservatives or 
sample refrigeration for transport are necessary before 
this technology can be used for diagnostic purposes.
The PCR/ESI-MS identified some of the bacteria 
present in highly contaminated milk, which contained 
more than 3 different microorganisms. However, this 
technology failed to identify some of the primary mas-
titis pathogens in 17.9% of the samples which may also 
be related to the prolonged transport time. Negative 
results of up to 12% were also reported for other PCR-
based assays compared with culture (Koskinen et al., 
2010). Otherwise, primary pathogens, such as Strep. 
uberis, Staph. aureus, Staphylococcus spp., A. pyogenes, 
and Mycoplasma spp., were identified. For those organ-
isms, the sensitivity of the PCR/ESI-MS ranged from 
57.1 to 100% and the specificity ranged from 69.8 to 
100% using culture as gold standard. Similar ranges 
were obtained when PCR-based molecular methods were 
compared with culture (Paradis et al., 2012; Spittel and 
Hoedemaker, 2012). However, molecular methods have 
been shown to higher detection potential than culture 
(Koskinen et al., 2009; Koskinen et al., 2010). We also 
show that the rapid detection of barely cultivatable and 
slow-growing mastitis pathogens, such as M. bovis, by 
PCR/ESI-MS represents a major advantage for veteri-
narians in preventing the spread of the disease within 
respective herds (Aebi et al., 2012). Indeed, the overall 
workflow for PCR/ESI-MS from receipt of a sample 
in the laboratory to providing organism identification 
requires approximately 8 h (Wolk et al., 2012). Ad-
ditionally, PCR/ESI-MS detected the presence of fungi, 
yeasts, and antibiotic-resistant genes. For example, 
Janthinobacterium lividum, an organism known to pos-
sess THIN-B, a metallo β-lactamase of class B3, was 
detected by PCR/ESI-MS (Docquier et al., 2004). The 
PCR/ESI-MS also detected the mecA gene, indicat-
ing the presence of methicillin-resistant staphylococci 
including methicillin-resistant Staph. aureus in bovine 
mastitis milk. The presence of these staphylococci in 
milk is a growing problem in veterinary medicine not 
only limiting antimicrobial treatment options, but also 
representing a burden for public health (Walther and 
Perreten, 2007; Vanderhaeghen et al., 2010; Holmes and 
Zadoks, 2011; Zadoks et al., 2011). Methicillin-resistant 
Staph. aureus present in milk may easily be transferred 
to humans through the consumption of raw milk or 
cheese (Perreten et al., 1998; Normanno et al., 2007). In 
this regard, PCR/ESI-MS could also find application 
for the direct determination of microbiological quality 
of bulk tank, raw milk to be used for raw milk products.
CONCLUSIONS
Our study demonstrates that PCR/ESI-MS possesses 
the potential to be a robust method used to screen for 
pathogens in the etiology of bovine mastitis. Even if the 
cost for analysis of a single sample on the PCR/ESI-MS 
system would be as high as a$50 to $100 per sample 
(quoted by Wolk et al., 2012), PCR/ESI-MS has the 
significant advantage that it can be adapted to differ-
ent settings and organisms (bacteria, mycobacteria, 
fungi, parasites, and viruses). The ability to perform 
a broad-range analysis on a variety of organism types 
without the need for culture or prior knowledge of the 
target may make the PCR/ESI-MS a more financially 
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feasible option than it appears at first glance. The 
broad range of bacterial and fungal DNA signatures 
detected by PCR/ESI-MS indicates that milk may also 
be a reservoir of genetic elements that are important in 
establishing the microbial flora of an individual, which 
may have consequences for therapy and public health. 
Accomplishing these identifications in less than 6 h, as 
compared with 24 to 72 h or longer for standard micro-
biological analyses, has significant implications for the 
dairy industry and veterinary medicine in the diagnosis 
of subclinical and clinical disease.
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